You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

CHANGES IN MYOCARDIUM UNDER CHRONIC EFFECT OF MERCURY CHLORIDE, USING UNITIOL AND KUERTSETIN AS CARDIOPROTECTORS

2(22) 2010

DOI xxxxxxxx

Kaminsky R.F.

CHANGES IN MYOCARDIUM UNDER CHRONIC EFFECT OF MERCURY CHLORIDE, USING UNITIOL AND KUERTSETIN AS CARDIOPROTECTORS

National Medical University, Kyiv

Full article (PDF), RUS

The paper describes morphological pathological changes in rat’s miocardium under chronic effect of mercury chloride. Basing on morphological studies, authors came to a conclusion that the use of such medicines as unitiol and kuertsetin allows to reduce the volume of irreversible pathological changes in myocardium. The results of the research can be used in preventive medicine, when developing practical recommendations for prevention of pathological changes, caused by cardiotoxic effect of mercury compounds.

Key words: mercury chloride, myocardium, unitiol, kuertsetin, rats, miocardium

References

  1. Trachtenberg IM., Korshun MM., Kozlov KP. (2006),“Mercury as a global chemical contaminant: ecologo-hygienic and clinico-hygienic aspects”, Dovkillya ta zdorovya, 2,12.
  2. Trakhtenberg I.M., Korshun M.M., Dmytrukha N.M. e.a. (2008), “Industrial toxicology: experience in scientific activity, excursus to the past”, Ukrainian Journal of Occupational Health, 4, 3-10.
  3. Moybenko A. A. Endogennyye mekhanizmy kardioprotektsii / A. A. Moybenko, A. M. Parkhomenko.- K., Naukova dumka.- 2008.- 210 s.
  4. Sokurenko L. M. Ispol'zovaniye issledovaniy in vitro dlya izucheniya neyrotoksichnosti rtuti / L. M. Sokurenko, YU. B. Chaykovskiy, YU. I. Kudryavets // Nauch. konf. s mezhdunarodnym uchastiyem: Meditsina truda, zdorov'ye rabotayushchego naseleniya. Sankt- Peterburg, 2009.- 2009.- S. 159-161.
  5. Trakhtenberg I. M. (1969), Khronicheskoye vozdeystviye rtuti na organizm: sovremennyy aspekt problemy merkurializma i yego profilaktiki [Chronic action of mercury on the body: the modern aspect of the problem of mercurialism and its prevention], Zdorovya, Kiev, Ukraine.
  6. Trakhtenberg I. M., Tychinin V.A. (2003), Problema kardiovazotoksicheskogo deystviya ekzogennykh khimicheskikh veshchestv, Ukr. kardíolohichnyi zhurnal, 5, 108 -113.
  7. Luganskiy N. I., Loboda YU. I. Prevrashcheniye unitiola v organizme / N. I. Luganskiy, YU. I. Loboda // Farmakol. i toksikol.- 1960.- T. 23, No 4.- S. 349-355.
  8. Metody otsinky antyoksydantnykh vlastyvostey fiziolohichno-aktyvnykh spoluk pry initsiyuvanni vilnoradykalnykh protsesiv u doslidakh in vitro / [Hubskyy YU. I., Dunayev V. V., Byelenichev I. F. ta in. ] // Metod. rekomendatsiyi Derzhfarmtsentru MOZ Ukrainy.- Kyiv, 2002.- 26 s.
  9. Korektsiya unitiolom porushen vilnoradykalnykh ta enerhozabezpechuvalnykh protsesiv u shchuriv z toksychnym urazhennyam pechinky / Honskyy YA. I., Kubant R. M., Korda M. M., Shuliha O. V // Medychna khimiya.- 2002.- T 4, No 1.- S. 46-49.
  10. Karp V. K. Unitiol - antydot toksychnykh metaliv / V. K. Karp, I. V. Danova // Liky.- 1997.- No 6.- S. 60-64.
  11. Antidotnaya effektivnost' resintezirovannogo unitiola / [Maksimov YU. N., Krasnyuk Ye. P., Ovrutskiy V. M. i dr. ] / / Sovr. probl. toksikol.- No 1.- S. 34-37.
  12. Meshchyshen I. F. Mekhanizm okysnyuvalnoyi modyfikatsiyi bilkiv / Meshchyshen I. F., Polovyy V. P. // Bukovynskyy med. visn.- 1999.- T. 3, No 1.- S. 196-205.
  13. Molekulyarnyye mekhanizmy deystviya ditiolov / Trinus F. P., Braver-Chernobul'skaya B. S., Chubenko A. V. i dr. ] // Vest. AMN SSSR,- 1984.- No 11.- S. 75-84.
  14. Holota L. H. Likuvalni ta antydotni vlastyvosti unitiolu / L. H. Holota // Farmatsevt, zhurn.- 1980.- No 1.- S. 18-22.
  15. Mizyukova I. G. Aktual'nyye voprosy patologii khimicheskoy etiologii / I. G. Mizyukova, V. Ye. Petrun'kin // Sb. farmakol. i toksikol.- 1983.- V. 18.- S. 73-78.
  16. Aaseth J. Treatment of mercury chloride poisoning with dimercaptosuscinic acid and diuretics: preliminary study / J. Aaseth, J. Alexander, N. Rakekud // Clin. Toxicol.- 1982.- V. 19.- P. 173.
  17. Kovalev V. B. Mekhanizmy lechebnogo deystviya bioflavonoida kvertsetina (obzor literatury) / B. Kovalev, V. V. Kovgan // Ukr. Med. Al'manakh.- 1999.- T 2, No 4.- S. 176-184.
  18. Pidvyshchennya efektyvnosti revaskulyaryzatsiyi miokarda shlyakhom blokady 5-lipoksyhenazy u khvorykh z hostrym koronarnym syndromom z elevatsiyeyu sehmenta ST / [O. M. Parkhomenko, S. M. Kozhukhov, YU. M. Sokolov ta in. ] // Ukrayinskyy kardiolohichnyy zhurnal.- No 6.- S. 6-9.
  19. Moybenko A. A. Effektivnost' vodorastvorimoy formy kvertsetina (korvitina) pri lechenii ostrogo koronarnogo sindroma s elevatsiyey segmenta ST / A. A. Moybenko, A. N. Parkhomenko, S. N. Kozhukhov // Zhurn. AMN Ukrainy.- 2003.- T 9, No 2.-361-370.
  20. Pervyy opyt primeneniya vnutrivennoy formy ingibitora 5-lipoksigenazy u bol'nykh s ostrym infarktom miokarda: kliniko-gemodinamicheskiye paralleli, vliyaniye preparata na razmery nekroza Parkhomenko A. N., Moybenko A. A., Kozhukhov S. N. i dr.] // Ukr. kardiol. zhurn.- 2000.- No 1-2.- S. 5-9.
  21. Parkhomenko A. N. Klinicheskaya effektivnost' vnutrivennoy formy kvertsetina u bol'nykh ostrym infarktom miokarda pri provedenii tromboliticheskoy terapii: realizatsiya kontseptsii otkrytoy koronarnoy arterii / A. N. Parkhomenko, S. N. Kozhukhov // Líki Ukraí̈ni.- 2000.- No 10.- S. 48-51.
  22. Tsellarius YU. G Morfologicheskiye tipy izmeneniya miofibrill myshechnykh kletok serdtsa / YU. G. Tsellarius, L. A. Semenova, L. M. Nepomnyashchikh // Arkh. patol.- 1980.- T XLP, No 12.- S. 3-13.